PA-20-070 Improving Medication Safety and Nursing Workflow during COVID Through eMAR Redesign
PA-20-070 Improving Medication Safety and Nursing Workflow during COVID Through eMAR Redesign
批准号:
10175229
负责人:
Raj M Ratwani
金额:
$24.53万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-04-30
中文摘要
项目总结/摘要
拟议的研究是对AHRQ PA-20-070的直接回应。我们的目标是支持护理工作流程,
减少与电子给药记录(eMAR)相关的患者安全危害,
(1)了解COVID-19前和COVID-19药物管理
通过分析健康信息技术和与护士的虚拟访谈的工作流程;和(2)
开发并向医疗机构传播药物管理工作流程风险评估工具
和卫生信息技术测试案例,以评估eMAR的可用性和安全性。我们将开发一个广泛的
了解用药管理工作流程的变化和医疗信息技术的需求,
通过比较与药物相互作用产生的电子数据,
技术在各个时期的应用。然后我们将与护士进行面谈,
验证药物管理工作流程,并生成流程图,以比较COVID-19前与
COVID-19药物管理工作流程,旨在识别安全风险。这些数据将告知
风险评估工具和可用性测试用例的开发将分发给医疗机构
和技术供应商。
该项目利用了研究团队在人为因素、健康信息、
技术、信息学和数据科学以及安全科学。我们的研究团队包括医生,护士,
人为因素工程师。该提案涉及提案征集的基本方面,
提供关于药物管理安全和健康信息技术的新见解,
新冠肺炎等大流行病的挑战。这项研究的贡献将包括一个基本的
了解医疗信息技术在药物管理过程中的作用,重点是
信息流,设计和开发医疗保健系统的风险评估工具和测试用例,
技术供应商,以应对COVID-19期间患者安全风险的增加。
英文摘要
PROJECT SUMMARY/ABSTRACT
The proposed research is in direct response to AHRQ PA-20-070. We aim to support nursing workflow and
reduce patient safety hazards associated with electronic medication administration records (eMARs) during
pandemics such as COVID-19 by: (1) understanding pre-COVID-19 and COVID-19 medication administration
workflows through analysis of health information technology and virtual interviews with nurses; and (2)
developing and disseminating a medication administration workflow risk assessment tool to healthcare facilities
and health information technology test cases to assess eMAR usability and safety. We will develop a broad
understanding of medication administration workflow changes and health information technology needs pre
COVDI-19 and during COVID-19 by comparing electronic data generated in interactions with medication
administration technology these respective time periods. We will then conduct interviews with nurses to
validate the medication administration workflows, and generate process maps to compare pre-COVID-19 vs.
COVID-19 medication administration workflows with the goal of identifying safety risks. These data will inform
the development of the risk assessment tool and usability test cases to be disseminated to healthcare facilities
and technology vendors.
This project utilizes the extensive expertise of the research team in human factors, health information
technology, informatics and data science, and safety science. Our research team includes physicians, nurses,
and human factors engineers. The proposal addresses fundamental aspects of the call for proposals by
providing new insights on medication administration safety and health information technology to address
challenges of pandemics such as COVID-19. Contributions from this research will include a fundamental
understanding of the role of health information technology during medication administration with a focus on
information flow, design, and development of a risk assessment tool and test cases for healthcare systems and
technology vendors to meet the increased risks to patient safety during COVID-19.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transforming Patient Safety Event Data into Actionable Insights through Advanced Analytics
-
批准号:10437655
-
项目类别:
-
资助金额:$38.82万
-
财政年份:2020
-
负责人:Raj M Ratwani
-
依托单位:
Transforming Patient Safety Event Data into Actionable Insights through Advanced Analytics
-
批准号:10249058
-
项目类别:
-
资助金额:$39.55万
-
财政年份:2020
-
负责人:Raj M Ratwani
-
依托单位:
Transforming Patient Safety Event Data into Actionable Insights through Advanced Analytics
-
批准号:10633121
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2020
-
负责人:Raj M Ratwani
-
依托单位:
Improving Patient Safety and Clinician Cognitive Support Through eMAR Redesign
-
批准号:9912124
-
项目类别:
-
资助金额:$39.85万
-
财政年份:2018
-
负责人:Raj M Ratwani
-
依托单位:
Developing Evidence- based User Centered Design and Implementation Guidelines to Improve Health Information Technology Usability
-
批准号:9322409
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2015
-
负责人:Raj M Ratwani
-
依托单位:
Developing Evidence- based User Centered Design and Implementation Guidelines to Improve Health Information Technology Usability
-
批准号:9750002
-
项目类别:
-
资助金额:$23.42万
-
财政年份:2015
-
负责人:Raj M Ratwani
-
依托单位:
Developing Evidence- based User Centered Design and Implementation Guidelines to Improve Health Information Technology Usability
-
批准号:9145193
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2015
-
负责人:Raj M Ratwani
-
依托单位:
Developing and Training Interruption Management Strategies for Emergency Physicia
-
批准号:8571056
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2013
-
负责人:Raj M Ratwani
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CDC20-HDAC6-POLD1轴调控肺腺癌免疫微环境的机制研究
-
批准号:2026JJ80369
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡智
-
依托单位:
CCL20/CCR6/SEMA3C信号轴通过EMT及肿瘤干细胞互作调控阴茎癌转移的分子机制研究
-
批准号:2026JJ50313
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡希恒
-
依托单位:
IFT20 抑制肝星状细胞活化并诱导其凋亡的机制研究
-
批准号:2026JJ82074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:金富昌
-
依托单位:
新型可降解聚酯P20-2C联合利福平根除关节假体表面细菌生物膜的机制与应用研究
-
批准号:2026JJ82609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱怡
-
依托单位:
USP20调控泛素化修饰介导微卫星稳定型结直肠癌免疫逃逸的机制研究
-
批准号:JCZRLH202600106
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
巴多昔芬通过重编程肿瘤相关巨噬细胞抑制CCL20介导的Treg募集并增敏乳腺癌免疫治疗的机制研究
-
批准号:JCZRQNB202600315
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
CL-20共晶/Al纳米复合炸药热分解-燃烧反应机理研究
-
批准号:JCZRLH202601722
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
SFRT激活新型STING调控因子协同CD3/CD20双抗治疗RR DLBCL的机制研究
-
批准号:JCZRLH202600672
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
亚20nm FinFET工艺下SRAM单粒子翻转机制及抗辐照加固关键技术研究
-
批准号:2026JJ60232
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:喻国芳
-
依托单位:
合肥长安燃油泵及支架总成1106100-DS20的研发及应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:冯国雄
-
依托单位: